Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Apolipoprotein E (apoE) is a crucial brain lipid transport protein synthesized by astrocytes.
• Astrocytes provide neuronal support and are vital for brain cholesterol homeostasis.
• Common human apoE isoforms (apoE2, apoE3, apoE4) differentially impact Alzheimer's disease (AD) risk and onset.

Purpose of the Study:

• To review conflicting hypotheses on apoE's role in AD pathogenesis.
• To examine therapeutic strategies targeting apoE for AD treatment.
• To offer perspectives on the rationale and challenges of targeting apoE.

Main Methods:

• Literature review of existing research on apoE and AD.
• Analysis of opposing hypotheses regarding apoE's contribution to AD.
• Evaluation of potential therapeutic approaches for targeting apoE.

Main Results:

• The ε4 allele is associated with increased AD risk; the ε2 allele offers protection.
• Conflicting results exist regarding apoE's precise role in AD development.
• Various strategies for targeting apoE as an AD therapeutic have been considered.

Conclusions:

• Targeting apoE presents a potential therapeutic avenue for AD.
• Significant challenges remain in developing 'drug-able' strategies for apoE.
• Further research is needed to reconcile conflicting findings and optimize apoE-based therapies.